Bioengineered Vascular Grafts for Hemodialysis Access: Design Requirements, Clinical Evidence, and Translational Barriers

{"Autogenous":[0],"arteriovenous":[1],"fistulas":[2],"(AVFs)":[3],"remain":[4,61],"the":[5,34,158,166],"preferred":[6],"hemodialysis":[7,83],"access":[8],"when":[9],"suitable":[10],"vessels":[11],"and":[12,24,60,68,91,109,123,144,165,170,180,212],"sufficient":[13],"maturation":[14],"time":[15],"are":[16,56,184],"available,":[17],"but":[18,131],"high":[19],"nonmaturation":[20],"rates,":[21],"catheter":[22],"dependence,":[23],"increasing":[25],"multimorbidity":[26],"in":[27],"end-stage":[28],"kidney":[29],"disease":[30],"(ESKD)":[31],"have":[32],"intensified":[33],"need":[35],"for":[36,82],"reliable":[37],"alternative":[38],"conduits.":[39],"Conventional":[40],"expanded":[41],"polytetrafluoroethylene":[42],"(ePTFE)":[43],"grafts":[44,78,127],"provide":[45],"an":[46],"immediately":[47],"available":[48],"surgical":[49],"option,":[50],"yet":[51],"their":[52],"chemically":[53],"inert":[54],"surfaces":[55],"not":[57],"intrinsically":[58],"blood-compatible":[59],"susceptible":[62],"to":[63,98],"thrombosis,":[64],"infection,":[65],"compliance":[66],"mismatch,":[67],"venous":[69],"neointimal":[70],"hyperplasia.":[71],"This":[72],"critical":[73],"review":[74],"evaluates":[75],"bioengineered":[76],"vascular":[77],"as":[79,186],"candidate":[80],"solutions":[81],"access,":[84],"emphasizing":[85],"how":[86],"material":[87],"design,":[88],"tissue-engineered":[89,126],"scaffolds,":[90,177],"localized":[92],"therapeutic":[93],"delivery":[94],"must":[95],"be":[96],"matched":[97],"dialysis-specific":[99],"requirements,":[100],"including":[101,157],"puncture":[102],"sealing,":[103],"suture":[104],"retention,":[105],"infection":[106],"resistance,":[107],"endothelialization,":[108],"high-flow":[110],"durability.":[111],"Early":[112],"clinical":[113,193],"experience":[114],"with":[115,205],"endogenous":[116],"tissue":[117],"restoration":[118],"grafts,":[119],"human":[120],"acellular":[121],"vessels,":[122],"scaffold-free":[124],"autologous":[125],"provides":[128],"encouraging":[129],"signals,":[130],"current":[132],"evidence":[133],"remains":[134],"limited":[135],"by":[136],"small":[137],"cohorts,":[138],"single-arm":[139],"designs,":[140],"incomplete":[141],"comparative":[142],"data,":[143],"uncertain":[145],"long-term":[146],"performance":[147],"under":[148],"repeated":[149],"cannulation.":[150],"We":[151],"also":[152],"examine":[153],"major":[154],"translational":[155],"barriers,":[156],"\\"uremic":[159],"mismatch\\"":[160],"between":[161],"healthy":[162],"animal":[163],"models":[164],"inflammatory,":[167],"calcified,":[168],"hypercoagulable,":[169],"immunologically":[171],"impaired":[172],"ESKD":[173,197],"milieu.":[174],"Finally,":[175],"immunomodulatory":[176],"4D-printed":[178],"structures,":[179],"biosensing":[181],"graft":[182,203],"concepts":[183],"discussed":[185],"experimental":[187],"research":[188],"directions":[189],"rather":[190],"than":[191],"established":[192],"solutions.":[194],"A":[195],"patient-centered,":[196],"Life-Plan-informed":[198],"strategy":[199],"may":[200],"ultimately":[201],"align":[202],"selection":[204],"vessel":[206],"quality,":[207],"life":[208],"expectancy,":[209],"dialysis":[210],"trajectory,":[211],"acceptable":[213],"intervention":[214],"burden.":[215]}